{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:05:03Z","timestamp":1781103903236,"version":"3.54.1"},"reference-count":48,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2002,3]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To present a case of ototoxicity induced by furosemide and once-daily gentamicin therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CASE SUMMARY:<\/jats:title>\n                    <jats:p>A 60-year-old white woman presented to the hospital with community-acquired pneumonia and urinary tract infection. The antibiotic regimen included gentamicin and, after 5 doses, the patient reported profound bilateral hearing loss. A Pure Tone Audiogram suggested moderate to moderately severe sensorineural hearing loss bilaterally. The only risk factors present included her age, elevated temperature, and the use of furosemide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"discussion\">\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>Several risk factors may predispose a patient to developing aminoglycoside ototoxicity: the 1555 chromosomal mutation, preexisting disorders of hearing and balance, hypovolemia, bacteremia, liver and renal dysfunction, and the simultaneous administration of other ototoxic medications. The cumulative dose and duration of aminoglycoside therapy are more important than serum concentrations. Administration of an aminoglycoside followed by furosemide may increase the risk of ototoxicity. The aminoglycoside interacts with the cell membranes in the inner ear, increasing their permeability. This theoretically allows the loop diuretic to penetrate into the cells in higher concentrations, causing more severe damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Auditory toxicity occurred after only 5 days of gentamicin therapy and 1 dose of furosemide. An aminoglycoside followed by furosemide may increase the risk for ototoxicity. Clinicians need to be aware of the synergistic potential of ototoxic medications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1a216","type":"journal-article","created":{"date-parts":[[2003,6,4]],"date-time":"2003-06-04T16:20:40Z","timestamp":1054743640000},"page":"446-451","source":"Crossref","is-referenced-by-count":65,"title":["Ototoxicity Induced by Gentamicin and Furosemide"],"prefix":"10.1177","volume":"36","author":[{"given":"Duane E","family":"Bates","sequence":"first","affiliation":[{"name":"Duane E Bates BSc Pharm, Staff Pharmacist, Internal Medicine, Foothills Medical Centre, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve J","family":"Beaumont","sequence":"additional","affiliation":[{"name":"Steve J Beaumont BSc MSc, Staff Audiologist, Audiology Consultants of Southern Alberta, Calgary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry W","family":"Baylis","sequence":"additional","affiliation":[{"name":"Barry W Baylis BSc MD FRCP, Staff Physician, Internal Medicine, Foothills Medical Centre"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2002,3]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/53.10.1141"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.796"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7027.338"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-8-199604150-00003"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.786"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/37.4.645"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936020-00001"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809002400312"},{"key":"e_1_2_1_10_2","first-page":"307","volume-title":"Principles and practice of infectious diseases","author":"Gilbert DN","year":"2000","unstructured":"Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000: 307\u201336.","edition":"5"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.650"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.6.797"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198019060-00002"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013861"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112463"},{"key":"e_1_2_1_16_2","volume-title":"American Hospital Formulary Service drug information","author":"McEvoy GK","year":"2001","unstructured":"McEvoy GK, ed. American Hospital Formulary Service drug information. Bethesda, MD: American Society of Health-System Pharmacists, 2001."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(20)30771-4"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614030-00006"},{"key":"e_1_2_1_19_2","first-page":"139","volume-title":"Audiology diagnosis","author":"Schwade ND","year":"2000","unstructured":"Schwade ND. Pharmacology in audiology practice. In: Roeser RJ, Valente M, Hosford-Dunn H, eds. Audiology diagnosis. New York: New York, 2000: 139\u201351."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(20)30763-5"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)79447-2"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.9.2209"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701831"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0709(97)90078-8"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0709(99)90054-6"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1383"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.1.23"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.2.236"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.1.320"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.1998.00224.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92803-3"},{"key":"e_1_2_1_32_2","unstructured":"Feder R. Tinnitus associated with amitriptyline. J Clin Psychiatry 1990; 85\u20136."},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1159\/000468565"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199106000-00021"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-5-744"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197801000-00029"},{"key":"e_1_2_1_37_2","first-page":"94","article-title":"Permanent deafness associated with furosemide administration","volume":"84","author":"Quick CA","year":"1975","unstructured":"Quick CA, Hoppe W. Permanent deafness associated with furosemide administration. Ann Otol 1975; 84: 94\u2013101.","journal-title":"Ann Otol"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(20)30770-2"},{"key":"e_1_2_1_39_2","first-page":"507","article-title":"Furosemide associated ototoxicity","volume":"2","author":"DeVito JM","year":"1983","unstructured":"DeVito JM, Vance JR. Furosemide associated ototoxicity. Clin Pharm 1983; 2: 507\u20138.","journal-title":"Clin Pharm"},{"key":"e_1_2_1_40_2","volume-title":"Compendium of pharmaceuticals and specialties","author":"Wellbanks L","year":"2000","unstructured":"Wellbanks L, ed. Compendium of pharmaceuticals and specialties. 35th ed. Ottawa, Canada: Canadian Pharmacists Association, 2000.","edition":"35"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196905292802208"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1985.02140070038027"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00455110"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197005000-00007"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra993637"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-2-204"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.4.380"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.3.245.30930"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1A216","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1A216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:06:08Z","timestamp":1777374368000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1A216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["10.1345\/aph.1A216"],"URL":"https:\/\/doi.org\/10.1345\/aph.1a216","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}